Patient-Centric Development: Keeping the Patient at the Heart of Commercializing New Medicines

18 Jan 2023
Commercializing the Therapies of the Future Track

1:00pm Chair Introduction

Tom Whitehead, Founder, Emily Whitehead Foundation


1:05pm Presentation: TBC

Speaker TBC 


1:20pm Presentation: TBC

Speaker TBC


1:35pm Presentation: TBA

Farah Speer, Senior Vice President, AviadoBio


1:50pm Presentation: TBC

Speaker TBC


2:05pm Closing Panel with Q&A

With all session participants joined by:

Sven Kili, CEO, Antion Biosciences


Farah Speer
Senior Vice President, Corporate Communications and External Relations
Sven Kili
Chief Executive Officer
Antion Biosciences